This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).

Inclusion Criteria for Patient Subjects:

• Aged 18 years or older

• Self-described African American race (patients who self-describe as "more than one race" will be included)

• Scheduled for new or consult oncology appointment at the study site

• Scheduled for return outpatient oncology appointment at the study site with a biopsy or radiology encounter within 2 weeks prior to provider visit.

  • for prostate cancer patients: 2 or more increasing prostate specific antigen (PSA) values i the 6 months prior to visit

• other patient identified by research team as potentially having a change in treatment prior to next outpatient oncology appointment at the study site

Inclusion Criteria for Provider Subjects:

• oncology provider at study site scheduled to see patients meeting criteria above

Exclusion Criteria for Patient Subjects:

• Estimated glomerular filtration rate (GFR) less than 30 ml/min/1.73m2 documented within last 2 months and without documented resolutions
• Bilirubin greater than 3.0 ng/dl documented within last 2 months and without documented resolution
• Initiated new anti-cancer therapy within last 2 months
• Evaluated for possible enrollment/randomization in the last 2 months
• Prior enrollment/randomization on this recruitment trial

Patient participants will not be informed of which intervention they are assigned.